Latest Insights - page 35 | BiopharmaTrend

Netherlands Outlines 2040 Biotech Vision, Emphasizing Tools, Commercialization, and Regulatory Reform

The Dutch government has released a national strategy to position the Netherlands as a global leader in biotechnology by 2040. The policy—backed by seven ministries—aims to accelerate innovation in health, …

Continue ›››

Sanger and PacBio Launch Long-Read Effort to Decode Immune Gene Activity

A new collaboration between the Wellcome Sanger Institute and Pacific Biosciences (PacBio) will apply long-read, single-cell RNA sequencing to nearly 1,500 blood and gut samples in an effort to understand …

Continue ›››

Finalists Announced for $10M Coller Dolittle Challenge on AI-Powered Interspecies Communication

The Coller Dolittle Challenge has announced its shortlist of four research teams competing for its inaugural $100,000 annual prize, part of a long-term effort to develop scientifically rigorous models of …

Continue ›››

BayPine Acquires Clinical Trial Network CenExel, Plans Digital Infrastructure and AI Expansion

CenExel Clinical Research, a U.S. site network specializing in complex therapeutic areas such as central nervous system (CNS) disorders, will be acquired by BayPine, a private investment firm focused on …

Continue ›››

Biostate AI to Develop Predictive Models for Multiple Sclerosis Using Transcriptomic Data

Biostate AI, a startup building AI models from RNA sequencing data, has partnered with the Accelerated Cure Project (ACP) to develop next-generation predictive tools for multiple sclerosis (MS). The collaboration …

Continue ›››

Scotland Launches ‘AI Discovery’ to Foster DeepTech AI Startups for NHS Healthcare Innovation

A new programme titled AI Discovery has been launched in Scotland to bridge advanced academic research with real-world healthcare applications through AI-enabled startups. Led by CodeBase through its government-backed Techscaler …

Continue ›››

Chiba University Researchers Develop Low-Cost Cell-Based Assay to Detect Chemical-Induced Epigenetic Changes

Researchers at Chiba University, in collaboration with Japan’s National Institute of Health Sciences, have developed a novel cell-based assay that detects epigenetic changes induced by environmental chemicals—a capability not addressed …

Continue ›››

FDA Plan to Replace Animal Testing with AI Models and Human-Based Methods in Drug Evaluation Shift

The U.S. Food and Drug Administration announced a major policy change on April 10, 2025, signaling its intent to reduce and potentially eliminate animal testing requirements for monoclonal antibodies and …

Continue ›››

Ingenix.ai Secures €9M to Advance Multimodal AI Foundation Model for Simulating Clinical Trials

Warsaw-based biotech company Ingenix.ai has closed a €9 million funding round to support the development of its proprietary foundation model for simulating clinical trials. Investors include Inovo, OTB Ventures, and …

Continue ›››

Recursion and Enamine Release AI-Curated Screening Libraries Targeting 100 Challenging Drug Targets

Recursion and Enamine announced the release of ten curated screening libraries generated through their AI-enabled collaboration. The libraries are designed to accelerate hit identification across 100 difficult-to-target areas of human …

Continue ›››

First Genetically Engineered Dire Wolf-Like Animals Born

De-extinction company Colossal Biosciences has produced three genetically engineered animals with dire wolf-like traits using a gene-editing approach applied to gray wolf cells. As reported in TIME on April 7, …

Continue ›››

Recursion Doses First Patient in Phase 1 Trial of AI-Designed MALT1 Inhibitor

Recursion has dosed the first patient in its Phase 1 EXCELERIZE trial of REC-3565, a selective MALT1 inhibitor targeting relapsed or refractory B-cell lymphomas. The compound was developed in 15 …

Continue ›››